Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Communicating Science to Business: a three part mini-course

22 October 2013

These workshops are designed to help to prepare academics looking to maximise the benefits of presenting their academic research to business audiences.

CPD

Attend all of the sessions to maximise the value of participating. Participants who attend three workshops in the same academic year will receive a CPD (Continued Personal Development) certificate to mark their achievements.